The data demonstrated that expression of TIGIT on CD4+ T cells is highly correlated with the SLE disease activity index (SLEDAI) suggesting TIGIT as a potential biomarker in monitoring disease activity in patients with SLE. The gene discussed is CD4; the disease is systemic lupus erythematosus.